OIASI Office / Pediatric Advisory Committee / office of Pediatric Therapeutics / Division of Surveillance / Research and Communication Support / Congress / HFD-960 office of Counter-Terrorism / Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation / Pediatric Exclusivity Board / FDA / MPH Division of Pediatric Drugs and Development / office of Drug Safety.** / /
Person
Michael C. Evans / Toni Piazza-Hepp / Solomon Iyasu / Informatics Extracted / M. Dianne Murphy / Sigal Kaplan / /
Position
Physician / Premier / Inpatient Drug Usage Utilizing Premier / Premier Network pediatric hospitals / Premier™ Rx Market Advisor / Acting Director / Director / Rx Market Advisor / Commissioner / EXECUTIVE / Pharmacist/Drug Use Specialist / /
Product
granisetron / cisplatin / Disintegrating Tablets / Anzemet / Outpatient Drug / Kytril / Patient Demographics Prescriptions / Zofran / A. Outpatient Drug Use I. Dispensed Prescriptions Outpatient prescriptions / Aloxi / Inpatient Drug / ondansetron / S-035 / HT3 / Use Data Zofran® (ondansetron HCl) / Zofran® Injection Premixed / Zofran® Orally Disintegrating Tablets / Zofran® Oral Solution / Zofran® Tablets / Zofran® Injection / Zofran® (ondansetron HCl) Injection / /
Department of Health and Human Services Public Health Service Food and Drug Administration